发明公开
- 专利标题： SEROTONIN REUPTAKE INHIBITORS
- 专利标题（中）： 选择性五羟色胺再摄取抑制剂
-
申请号： EP11773367.5申请日： 2011-10-10
-
公开(公告)号： EP2627630A1公开(公告)日： 2013-08-21
- 发明人: STANGELAND, Eric L. , PATTERSON, Lori Jean , SAITO, Daisuke Roland
- 申请人： Theravance, Inc.
- 申请人地址： 901 Gateway Boulevard South San Francisco, CA 94080 US
- 专利权人： Theravance, Inc.
- 当前专利权人： Theravance, Inc.
- 当前专利权人地址： 901 Gateway Boulevard South San Francisco, CA 94080 US
- 代理机构： Scott, Susan Margaret
- 优先权： US391758P 20101011
- 国际公布： WO2012051103 20120419
- 主分类号： C07D207/08
- IPC分类号： C07D207/08 ; C07D401/12 ; A61K31/40 ; A61P11/00
摘要：
In one aspect, the invention relates to compounds of formula I: (I) where X, Y, R
1 , R
2 , R
3 , R
4 , R
4 , and n are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
1 , R
2 , R
3 , R
4 , R
4 , and n are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
公开/授权文献
- EP2627630B1 SEROTONIN REUPTAKE INHIBITORS 公开/授权日：2014-12-31
信息查询
